|
|
|
|
|
|
|
|
|
FORM 10-Q |
||
|
|
|
|
|
|
(Check One)
x QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2012
o TRANSITION
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT
For the transition period from ______ to ______
COMMISSION FILE NO. (0-16577)
|
|
|
|
|
|
|
|
|
|
CYBEROPTICS CORPORATION |
|
(Exact name of registrant as specified in its charter) |
|
|
|
Minnesota |
|
41-1472057 |
(State or other jurisdiction of |
|
(I.R.S. Employer |
incorporation or organization) |
|
Identification No.) |
|
|
|
5900 Golden Hills Drive |
|
|
MINNEAPOLIS, MINNESOTA |
|
55416 |
(Address of principal executive offices) |
|
(Zip Code) |
|
|
|
(763) 542-5000 |
||
(Registrants telephone number, including area code) |
|
|
|
|
|
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or
for such shorter period that the registrant was required to submit and post
such files).
Yes x No o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of accelerated filer or large accelerated filer in Rule 12b-2 of the Exchange Act.
|
|
|
|
Large accelerated filer o |
Accelerated filer o |
Non-accelerated filer o |
Smaller Reporting Company x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date. At April 30, 2012, there were 6,933,116 shares of the registrants Common Stock, no par value, issued and outstanding.
PART I. FINANCIAL INFORMATION
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
CYBEROPTICS CORPORATION
(Unaudited)
|
|
|
|
|
|
|
|
(In thousands except share information) |
|
March 31, |
|
December 31, |
|
||
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
9,940 |
|
$ |
13,791 |
|
Marketable securities |
|
|
11,697 |
|
|
10,640 |
|
Accounts receivable, less allowance for doubtful accounts of $890 at March 31, 2012 and $940 at December 31, 2011 |
|
|
10,334 |
|
|
11,909 |
|
Inventories |
|
|
12,550 |
|
|
11,052 |
|
Income tax refunds receivable |
|
|
187 |
|
|
196 |
|
Other current assets |
|
|
1,367 |
|
|
1,238 |
|
Deferred tax assets, net |
|
|
2,381 |
|
|
2,518 |
|
Total current assets |
|
|
48,456 |
|
|
51,344 |
|
|
|
|
|
|
|
|
|
Marketable securities, long-term |
|
|
9,737 |
|
|
6,106 |
|
Equipment and leasehold improvements, net |
|
|
1,555 |
|
|
1,400 |
|
Intangible and other assets, net |
|
|
214 |
|
|
230 |
|
Goodwill |
|
|
569 |
|
|
569 |
|
Other assets |
|
|
139 |
|
|
137 |
|
Deferred tax assets, net |
|
|
3,106 |
|
|
3,130 |
|
Total assets |
|
$ |
63,776 |
|
$ |
62,916 |
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
5,115 |
|
$ |
4,081 |
|
Advance customer payments |
|
|
685 |
|
|
655 |
|
Accrued expenses |
|
|
2,836 |
|
|
3,657 |
|
Total current liabilities |
|
|
8,636 |
|
|
8,393 |
|
|
|
|
|
|
|
|
|
Deferred rent |
|
|
388 |
|
|
327 |
|
Extended warranty liability |
|
|
265 |
|
|
353 |
|
Deferred tax liability |
|
|
34 |
|
|
34 |
|
Reserve for income taxes |
|
|
844 |
|
|
840 |
|
Total liabilities |
|
|
10,167 |
|
|
9,947 |
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity: |
|
|
|
|
|
|
|
Preferred stock, no par value, 5,000,000 shares authorized, none outstanding |
|
|
|
|
|
|
|
Common stock, no par value, 25,000,000 shares authorized, 6,933,116 shares issued and outstanding at March 31, 2012 and 6,933,029 shares issued and outstanding at December 31, 2011 |
|
|
31,046 |
|
|
30,965 |
|
Accumulated other comprehensive loss |
|
|
(459 |
) |
|
(926 |
) |
Retained earnings |
|
|
23,022 |
|
|
22,930 |
|
Total stockholders equity |
|
|
53,609 |
|
|
52,969 |
|
Total liabilities and stockholders equity |
|
$ |
63,776 |
|
$ |
62,916 |
|
SEE THE ACCOMPANYING NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
2
CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS
CYBEROPTICS CORPORATION
(Unaudited)
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
||||
(In thousands, except per share amounts) |
|
2012 |
|
2011 |
|
||
|
|
|
|
|
|
|
|
Revenues |
|
$ |
11,280 |
|
$ |
13,350 |
|
Cost of revenues |
|
|
6,045 |
|
|
6,743 |
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
5,235 |
|
|
6,607 |
|
|
|
|
|
|
|
|
|
Research and development expenses |
|
|
1,917 |
|
|
1,818 |
|
Selling, general and administrative expenses |
|
|
3,226 |
|
|
3,657 |
|
Amortization of intangibles |
|
|
|
|
|
45 |
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
92 |
|
|
1,087 |
|
|
|
|
|
|
|
|
|
Interest income and other |
|
|
35 |
|
|
86 |
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
127 |
|
|
1,173 |
|
|
|
|
|
|
|
|
|
Income tax provision |
|
|
35 |
|
|
327 |
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
92 |
|
$ |
846 |
|
|
|
|
|
|
|
|
|
Net income per share Basic |
|
$ |
0.01 |
|
$ |
0.12 |
|
Net income per share Diluted |
|
$ |
0.01 |
|
$ |
0.12 |
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding Basic |
|
|
6,933 |
|
|
6,891 |
|
Weighted average shares outstanding Diluted |
|
|
6,982 |
|
|
6,935 |
|
SEE THE ACCOMPANYING NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
3
CONDENSED CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME
CYBEROPTICS CORPORATION
(Unaudited)
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
||||
(In thousands) |
|
2012 |
|
2011 |
|
||
|
|
|
|
|
|
|
|
Net income |
|
$ |
92 |
|
$ |
846 |
|
Other comprehensive income (loss), before tax: |
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
211 |
|
|
98 |
|
Unrealized gains (losses) on available-for-sale securities |
|
|
(6 |
) |
|
10 |
|
Unrealized gains (losses) on foreign exchange forward contracts: |
|
|
|
|
|
|
|
Unrealized gains (losses) on foreign exchange forward contracts for the period |
|
|
323 |
|
|
(26 |
) |
Reclassification adjustment for gains included in net income |
|
|
75 |
|
|
27 |
|
Total unrealized gains on foreign exchange forward contracts |
|
|
398 |
|
|
1 |
|
|
|
|
|
|
|
|
|
Other comprehensive income, before tax |
|
|
603 |
|
|
109 |
|
|
|
|
|
|
|
|
|
Income tax expense related to items of other comprehensive income |
|
|
(136 |
) |
|
(3 |
) |
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
|
467 |
|
|
106 |
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
$ |
559 |
|
$ |
952 |
|
SEE THE ACCOMPANYING NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
4
CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOWS
CYBEROPTICS CORPORATION
(Unaudited)
|
|
Three Months Ended March 31, |
|
||||
(In thousands) |
|
2012 |
|
2011 |
|
||
|
|
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
Net income |
|
$ |
92 |
|
$ |
846 |
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
410 |
|
|
643 |
|
Provision for doubtful accounts |
|
|
(48 |
) |
|
|
|
Deferred taxes |
|
|
|
|
|
255 |
|
Foreign currency transaction (gains) losses |
|
|
10 |
|
|
(80 |
) |
Stock compensation costs |
|
|
105 |
|
|
106 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
Accounts receivable |
|
|
1,623 |
|
|
260 |
|
Inventories |
|
|
(1,438 |
) |
|
(359 |
) |
Income tax refunds receivable |
|
|
9 |
|
|
(19 |
) |
Other assets |
|
|
(91 |
) |
|
138 |
|
Accounts payable |
|
|
970 |
|
|
(872 |
) |
Advance customer payments |
|
|
(58 |
) |
|
(298 |
) |
Accrued expenses |
|
|
(379 |
) |
|
(160 |
) |
Net cash provided by operating activities |
|
|
1,205 |
|
|
460 |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
Proceeds from maturities of available-for-sale marketable securities |
|
|
2,592 |
|
|
3,735 |
|
Proceeds from sales of available-for-sale marketable securities |
|
|
1,350 |
|
|
1,048 |
|
Purchases of available-for-sale marketable securities |
|
|
(8,638 |
) |
|
(4,040 |
) |
Additions to equipment and leasehold improvements |
|
|
(412 |
) |
|
(76 |
) |
Additions to patents |
|
|
(25 |
) |
|
(29 |
) |
Net cash provided by (used in) investing activities |
|
|
(5,133 |
) |
|
638 |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
Proceeds from issuance of stock options |
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effects of exchange rate changes on cash and cash equivalents |
|
|
77 |
|
|
24 |
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents |
|
|
(3,851 |
) |
|
1,122 |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents beginning of period |
|
|
13,791 |
|
|
8,427 |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents end of period |
|
$ |
9,940 |
|
$ |
9,549 |
|
SEE THE ACCOMPANYING NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
5
NOTES TO THE (UNAUDITED) INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS CYBEROPTICS CORPORATION
1. INTERIM REPORTING:
The interim condensed consolidated financial statements presented herein as of March 31, 2012, and for the three month periods ended March 31, 2012 and 2011, are unaudited, but in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position, results of operations and cash flows for the periods presented.
The results of operations for the three month period ended March 31, 2012 do not necessarily indicate the results to be expected for the full year. The December 31, 2011 consolidated balance sheet data was derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. These unaudited interim condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto, contained in our Annual Report on Form 10-K for the year ended December 31, 2011.
2. MARKETABLE SECURITIES:
Our investments in marketable securities are classified as available-for-sale and consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2012 |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
Cost |
|
Unrealized |
|
Unrealized |
|
Fair Value |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agency obligations |
|
$ |
7,637 |
|
$ |
11 |
|
$ |
|
|
$ |
7,648 |
|
Corporate debt securities and certificates of deposit |
|
|
4,044 |
|
|
5 |
|
|
|
|
|
4,049 |
|
Marketable securities short-term |
|
$ |
11,681 |
|
$ |
16 |
|
$ |
|
|
$ |
11,697 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agency obligations |
|
$ |
7,010 |
|
$ |
22 |
|
$ |
(2 |
) |
$ |
7,030 |
|
Corporate debt securities and certificates of deposit |
|
|
2,637 |
|
|
8 |
|
|
(2 |
) |
|
2,643 |
|
Equity security |
|
|
84 |
|
|
|
|
|
(20 |
) |
|
64 |
|
Marketable securities long-term |
|
$ |
9,731 |
|
$ |
30 |
|
$ |
(24 |
) |
$ |
9,737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2011 |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
Cost |
|
Unrealized |
|
Unrealized |
|
Fair Value |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agency obligations |
|
$ |
6,495 |
|
$ |
8 |
|
$ |
|
|
$ |
6,503 |
|
Corporate debt securities and certificates of deposit |
|
|
4,133 |
|
|
4 |
|
|
|
|
|
4,137 |
|
Marketable securities short-term |
|
$ |
10,628 |
|
$ |
12 |
|
$ |
|
|
$ |
10,640 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agency obligations |
|
$ |
3,653 |
|
$ |
28 |
|
$ |
(1 |
) |
$ |
3,680 |
|
Corporate debt securities and certificates of deposit |
|
|
2,353 |
|
|
9 |
|
|
(2 |
) |
|
2,360 |
|
Equity security |
|
|
84 |
|
|
|
|
|
(18 |
) |
|
66 |
|
Marketable securities long-term |
|
$ |
6,090 |
|
$ |
37 |
|
$ |
(21 |
) |
$ |
6,106 |
|
6
Our investments in marketable debt securities all have maturities of less than three years. At March 31, 2012, marketable debt securities valued at $18,126,000 were in an unrealized gain position totaling $46,000 and marketable debt securities valued at $3,244,000 were in an insignificant unrealized loss position totaling $4,000 (all had been in an unrealized loss position for less than twelve months). At December 31, 2011, marketable debt securities valued at $14,207,000 were in an unrealized gain position totaling $49,000 and marketable debt securities valued at $2,473,000 were in an insignificant unrealized loss position totaling $3,000 (all had been in an unrealized loss position for less than twelve months). The one equity security we hold has been in an unrealized loss position for less than one year.
Net pre-tax unrealized gains for marketable securities of $22,000 at March 31, 2012 and $28,000 at December 31, 2011 were recorded as a component of accumulated other comprehensive income (loss) in stockholders equity. In the three months ended March 31, 2012 we received proceeds of $1,350,000 from the sale of marketable securities. In the three months ended March 31, 2011 we received proceeds of $1,048,000 from the sale of marketable securities. No gain or loss was recognized on any of the sales during the three months ended March 31, 2012 or 2011.
Investments in marketable securities classified as cash equivalents of $1,001,000 at March 31, 2012 and $685,000 at December 31, 2011 consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2012 |
|
||||||||||
(In thousands) |
|
Cost |
|
Unrealized |
|
Unrealized |
|
|
Recorded |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agency obligations |
|
$ |
520 |
|
$ |
|
|
$ |
|
|
$ |
520 |
|
Corporate debt securities and certificates of deposit |
|
|
481 |
|
|
|
|
|
|
|
|
481 |
|
|
|
$ |
1,001 |
|
$ |
|
|
$ |
|
|
$ |
1,001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2011 |
|
||||||||||
(In thousands) |
|
Cost |
|
Unrealized |
|
Unrealized |
|
Recorded |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agency obligations |
|
$ |
30 |
|
$ |
|
|
$ |
|
|
$ |
30 |
|
Corporate debt securities and certificates of deposit |
|
|
655 |
|
|
|
|
|
|
|
|
655 |
|
|
|
$ |
685 |
|
$ |
|
|
$ |
|
|
$ |
685 |
|
Cash held in foreign accounts totaled $2,033,000 at March 31, 2012 and $2,296,000 at December 31, 2011.
3. DERIVATIVES:
We enter into foreign exchange forward contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies and certain intercompany financing transactions associated with our subsidiaries in the United Kingdom and Singapore. These transactions are designated as cash flow hedges. The effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. Hedge ineffectiveness and the amounts excluded from effectiveness testing recognized in income on cash flow hedges were not material for the three month periods ended March 31, 2012 and March 31, 2011.
The maximum length of time over which we hedge our exposure to the variability in future cash flows is 12 months. Accordingly, at March 31, 2012 and March 31, 2011, all of our open foreign exchange forward contracts had maturities of one year or less. The dollar equivalent gross notional amount of our foreign exchange forward contracts designated as cash flow hedges was approximately $10.8 million at March 31, 2012 and $9.7 million at March 31, 2011.
7
The location in the consolidated statements of operations and comprehensive income and amounts of gains and losses related to derivative instruments designated as cash flow hedges are as follows. Reclassifications of amounts from accumulated other comprehensive income into income include accumulated gains (losses) at the time earnings are impacted by the forecasted transaction.
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2012 |
|
|||||||
(In thousands) |
|
Pretax Gain (Loss) |
|
Pretax Gain (Loss) |
|
Ineffective Portion of |
|
|||
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
$ |
228 |
|
$ |
(52 |
) |
$ |
|
|
Research and development |
|
|
53 |
|
|
(13 |
) |
|
|
|
Sales and marketing |
|
|
42 |
|
|
(10 |
) |
|
|
|
Other income |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
323 |
|
$ |
(75 |
) |
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2011 |
|
|||||||
(In thousands) |
|
Pretax Gain (Loss) |
|
Pretax Gain (Loss) |
|
Ineffective Portion of |
|
|||
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
$ |
2 |
|
$ |
1 |
|
$ |
|
|
Research and development |
|
|
1 |
|
|
1 |
|
|
|
|
Sales and marketing |
|
|
1 |
|
|
1 |
|
|
|
|
Other income |
|
|
(30 |
) |
|
(30 |
) |
|
|
|
Total |
|
$ |
(26 |
) |
$ |
(27 |
) |
$ |
|
|
Amounts recorded in accumulated other comprehensive loss for the after tax net unrealized loss associated with cash flow hedging instruments was $63,000 as of March 31, 2012 and $323,000 as of December 31, 2011. We expect to reclassify the March 31, 2012 after tax net unrealized loss recorded in accumulated other comprehensive loss to earnings over the next 12 months with the impact offset by cash flows from underlying hedged items. The fair value of our foreign exchange forward contracts representing a loss in the amount of $97,000 as of March 31, 2012 and $493,000 as of December 31, 2011 has been recorded in accrued expenses in the accompanying consolidated balance sheets.
Additional information with respect to the impact of derivative instruments on other comprehensive income is included in Note 10. Additional information with respect to the fair value of derivative instruments is included in Note 4.
Our foreign exchange forward contracts contain credit risk to the extent that our bank counter-parties may be unable to meet the terms of the agreements. We minimize such risk by limiting our counter-parties to major financial institutions. We do not expect material losses as a result of defaults by other parties.
8
4. FAIR VALUE MEASUREMENTS:
We determine the fair value of our assets and liabilities based on the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. We use a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1). The next highest priority is based on quoted prices for similar assets or liabilities in active markets or quoted prices for identical or similar assets or liabilities in non-active markets or other observable inputs (Level 2). The lowest priority is given to unobservable inputs (Level 3). The following provides information regarding fair value measurements for our marketable securities and foreign exchange forward contracts as of March 31, 2012 and December 31, 2011 according to the three-level fair value hierarchy:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at March 31, 2012 Using |
|
||||||||||
(In thousands) |
|
Balance |
|
Quoted Prices |
|
Significant |
|
Significant |
|
||||
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agency |
|
$ |
14,678 |
|
$ |
|
|
$ |
14,678 |
|
$ |
|
|
Corporate debt securities and |
|
|
6,692 |
|
|
|
|
|
6,692 |
|
|
|
|
Equity security |
|
|
64 |
|
|
64 |
|
|
|
|
|
|
|
Total marketable securities |
|
$ |
21,434 |
|
$ |
64 |
|
$ |
21,370 |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments-liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange forward contracts |
|
$ |
(97 |
) |
$ |
|
|
$ |
(97 |
) |
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at December 31, 2011 Using |
|
||||||||||
(In thousands) |
|
Balance |
|
Quoted Prices |
|
Significant |
|
Significant |
|
||||
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and agency |
|
$ |
10,183 |
|
$ |
|
|
$ |
10,183 |
|
$ |
|
|
Corporate debt securities and |
|
|
6,497 |
|
|
|
|
|
6,497 |
|
|
|
|
Equity security |
|
|
66 |
|
|
66 |
|
|
|
|
|
|
|
Total marketable securities |
|
$ |
16,746 |
|
$ |
66 |
|
$ |
16,680 |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments-liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange forward contracts |
|
$ |
(493 |
) |
$ |
|
|
$ |
(493 |
) |
$ |
|
|
During the three months ended March 31, 2012 there were no significant transfers to or from the three level hierarchy. A significant transfer is recognized when the inputs used to value a security have been changed which merit a transfer between the disclosed levels of the valuation hierarchy.
9
The fair value for our U.S. government and agency obligations, corporate debt securities and certificates of deposit and asset backed securities are determined based on valuations provided by external investment managers who obtain them from a variety of industry standard data providers. The fair value for our equity security is based on a quoted market price obtained from an active market.
The fair value for our foreign exchange forward contracts are based on foreign currency spot and forward rates obtained from reputable financial institutions with resulting valuations periodically validated by obtaining foreign currency spot rate and forward quotes from other industry standard sources or third party or counterparty quotes. The fair value of our foreign exchange forward contracts representing a loss in the amount of $97,000 as of March 31, 2012 and $493,000 as of December 31, 2011 has been recorded in accrued expenses in the accompanying consolidated balance sheets.
The carrying amounts of financial instruments such as cash equivalents, accounts receivable, other assets, accounts payable, accrued expenses and other current liabilities approximate the related fair values due to the short-term maturities of these instruments. Non-financial assets such as equipment and leasehold improvements, goodwill and intangible assets are subject to non-recurring fair value measurements if they are deemed impaired. We had no re-measurements of non-financial assets to fair value during the three months ended March 31, 2012 or March 31, 2011.
5. ACCOUNTING FOR STOCK-BASED COMPENSATION:
All equity-based payments to employees, including grants of employee stock options, are recognized as an expense in our consolidated statement of operations based on the grant date fair value of the award. We utilize the straight-line method of expense recognition over the awards service period for our graded vesting options. The fair value of stock options granted has been determined using the Black-Scholes model. The compensation expense recognized for all equity based awards is net of estimated forfeitures, which are based on historical data. We have classified equity based compensation within our statement of operations in the same manner as our cash based employee compensation costs.
Equity based compensation expense in the three months ended March 31, 2012 totaled $105,000 and includes $64,000 for stock option awards, $15,000 for our employee stock purchase plan, and $26,000 for unvested restricted stock units. Equity based compensation expense in the three months ended March 31, 2011 totaled $106,000 and includes $57,000 for stock option awards, $26,000 for our employee stock purchase plan, and $23,000 for unvested restricted stock units.
At March 31, 2012, the total unrecognized compensation cost related to non-vested equity based compensation arrangements was $914,000 and the related weighted average period over which it is expected to be recognized is 2.08 years.
Stock Options
We have two stock incentive plans that are administered under the supervision of the Compensation Committee of the Board of Directors. There are 732,689 shares of common stock reserved in the aggregate for issuance of options and other stock based benefits under these plans, including restricted stock units and share grants to employees, officers and others. Reserved shares underlying canceled options are available for future grant under our active plans. Options are granted at an option price per share equal to or greater than the market value on the date of grant. Generally, options granted to employees vest over a four-year period and expire five, seven, or ten years after the date of grant. As of March 31, 2012, there were 128,163 shares of common stock available under these plans for future issuance to employees, officers and others.
The following is a summary of stock option activity during the three months ended March 31, 2012:
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
Weighted Average |
|
||
|
|
|
|
|
|
|
|
Outstanding, December 31, 2011 |
|
|
515,987 |
|
$ |
10.07 |
|
Granted |
|
|
105,833 |
|
|
7.30 |
|
Exercised |
|
|
|
|
|
|
|
Expired |
|
|
(58,000 |
) |
|
12.15 |
|
Forfeited |
|
|
|
|
|
|
|
Outstanding, March 31, 2012 |
|
|
563,820 |
|
$ |
9.33 |
|
|
|
|
|
|
|
|
|
Exercisable, March 31, 2012 |
|
|
332,463 |
|
$ |
10.51 |
|
10
The intrinsic value of an option is the amount by which the fair value of the underlying stock exceeds its exercise price. At March 31, 2012, the weighted average remaining contractual term of all outstanding options was 3.94 years and their aggregate intrinsic value was $984,347. At March 31, 2012, the weighted average remaining contractual term of options that were exercisable was 2.68 years and their aggregate intrinsic value was $470,517. There were no proceeds from the exercise of stock options in the three months ended March 31, 2012 or 2011.
The fair values of the options granted to our employees were estimated on the date of grant using the Black-Scholes model. The Black-Scholes valuation model incorporates ranges of assumptions that are disclosed in the table below. The risk-free interest rate is based on the United States Treasury yield curve at the time of grant with a remaining term equal to the expected life of the awards. For options granted in the three months ending March 31, 2012, we estimated the expected term for our graded vesting options, representing the length of time in years that the options are expected to be outstanding, using historical experience. Previously, we used the simplified method for expected term because our historical exercise experience was not expected to be representative of future exercise patterns. Expected volatility was computed based on historical fluctuations in the daily price of our common stock.
For stock options granted during the three months ended March 31, 2012, we utilized the fair value of our common stock on the date of grant and employed the following key assumptions in computing fair value using the Black-Scholes option-pricing model:
|
|
|
|
|
|
|
2012 |
||
|
|
|
|
|
Risk-free interest rates |
|
|
0.86 |
% |
|
|
|
|
|
Expected life in years |
|
|
4.95 |
|
|
|
|
|
|
Expected volatility |
|
|
45.81 |
% |
|
|
|
|
|
Dividend yield |
|
|
0.00 |
% |
Weighted average fair value on grant date |
|
|
$2.94 |
|
|
|
|
|
|
Restricted Stock Units
Our 1998 Stock Incentive Plan also permits our Compensation Committee to grant other stock-based benefits, including restricted stock units. Restricted stock units are valued at a price equal to the fair market value of our common stock on the date of grant, vest over a four year period and entitle the holders to one share of our common stock for each restricted stock unit. The aggregate fair value of outstanding restricted stock units as of March 31, 2012 was $393,000.
A summary of activity in non-vested restricted stock units for the three months ended March 31, 2012 is as follows:
|
|
|
|
|
|
|
|
Non-vested restricted stock units |
|
Shares |
|
Weighted
Average |
|
||
|
|||||||
Non-vested at December 31, 2011 |
|
|
19,404 |
|
$ |
7.58 |
|
Granted |
|
|
21,389 |
|
|
7.30 |
|
Vested |
|
|
(87 |
) |
|
7.71 |
|
Forfeited |
|
|
|
|
|
|
|
Non-vested at March 31, 2012 |
|
|
40,706 |
|
$ |
7.43 |
|
Employee Stock Purchase Plan
We have an Employee Stock Purchase Plan available to eligible U.S. employees. Under terms of the plan, eligible employees may designate from 1% to 10% of their compensation to be withheld through payroll deductions, up to a maximum of $6,500 in each plan year, for the purchase of common stock at 85% of the lower of the market price on the first or last day of the offering period. There were no shares issued under this plan in the three months ended March 31, 2012 or March 31, 2011. As of March 31, 2012, 186,341 shares remain available for future issuance under this plan.
11
Stock Grant Plan for Non-Employee Directors
Our stock grant plan for non-employee directors provides for automatic grants of 1,000 shares of our common stock to each of our non-employee directors upon their re-election to the board of directors. The plan provides for a total of 30,000 shares of our common stock for issuance to directors and will expire on May 19, 2018. No shares were issued under this plan in the three months ended March 31, 2012 or March 31, 2011. There are presently 16,000 shares of common stock reserved in the aggregate for future issuance under this plan.
6. INVENTORIES AND WARRANTIES:
Inventories consist of the following:
|
|
|
|
|
|
|
|
(In thousands) |
|
March 31, 2012 |
|
December 31, 2011 |
|
||
|
|
|
|
|
|
|
|
Raw materials and purchased parts |
|
$ |
7,639 |
|
$ |
6,893 |
|
Work in process |
|
|
1,227 |
|
|
1,007 |
|
Finished goods |
|
|
3,684 |
|
|
3,152 |
|
|
|
|
|
|
|
|
|
Total inventories |
|
$ |
12,550 |
|
$ |
11,052 |
|
Warranty costs:
We provide for the estimated cost of product warranties at the time revenue is recognized, generally for one year. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of component suppliers, warranty obligations are affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure. Should actual product failure rates, material usage or service delivery costs differ from our estimates, revisions to the estimated warranty liability would be required. Our warranty liability is included as a component of accrued expenses. At the end of each reporting period we revise our estimated warranty liability based on these factors.
A reconciliation of the changes in our estimated warranty liability is as follows:
|
|
|
|
|
|
|
|
|
|
Three
Months Ended |
|
||||
(In thousands) |
|
2012 |
|
2011 |
|
||
|
|
|
|
|
|
|
|
Balance at beginning of period |
|
$ |
985 |
|
$ |
702 |
|
Accrual for warranties |
|
|
332 |
|
|
185 |
|
Settlements made during the period |
|
|
(301 |
) |
|
(191 |
) |
|
|
|
|
|
|
|
|
Balance at end of period |
|
$ |
1,016 |
|
$ |
696 |
|
Extended warranty:
The current portion of our extended warranty liability is included as a component of advance customer payments. A reconciliation of the changes in our extended warranty liability is as follows:
|
|
|
|
|
|
|
|
|
|
Three
Months Ended |
|
||||
(In thousands) |
|
2012 |
|
2011 |
|
||
|
|
|
|
|
|
|
|
Balance at beginning of period |
|
$ |
806 |
|
$ |
787 |
|
Revenue deferrals |
|
|
46 |
|
|
86 |
|
Amortization of deferred revenue |
|
|
(105 |
) |
|
(110 |
) |
Total extended warranty liability |
|
|
747 |
|
|
763 |
|
Current portion of extended warranty liability |
|
|
(482 |
) |
|
(410 |
) |
|
|
|
|
|
|
|
|
Long-term extended warranty liability |
|
$ |
265 |
|
$ |
353 |
|
12
7. INTANGIBLE ASSETS:
Intangible assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2012 |
|
December 31, 2011 |
|
||||||||||||||
(In thousands) |
|
Gross |
|
Accumulated |
|
Net |
|
Gross |
|
Accumulated |
|
Net |
|
||||||
|
|||||||||||||||||||
Developed technology |
|
$ |
7,775 |
|
$ |
(7,775 |
) |
$ |
|
|
$ |
7,775 |
|
$ |
(7,775 |
) |
$ |
|
|
Patents |
|
|
2,759 |
|
|
(2,545 |
) |
|
214 |
|
|
2,734 |
|
|
(2,504 |
) |
|
230 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
10,534 |
|
$ |
(10,320 |
) |
$ |
214 |
|
$ |
10,509 |
|
$ |
(10,279 |
) |
$ |
230 |
|
Amortization expense for the three month periods ended March 31, 2012 and 2011 is as follows:
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
||||
(In thousands) |
|
2012 |
|
2011 |
|
||
|
|
|
|
|
|
|
|
Developed technology |
|
$ |
|
|
$ |
45 |
|
Patents |
|
|
41 |
|
|
59 |
|
|
|
|
|
|
|
|
|
|
|
$ |
41 |
|
$ |
104 |
|
Intangible and other long lived assets are reviewed for impairment when events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. An impairment loss would be recognized when future undiscounted cash flows expected to result from use of the asset and eventual disposition are less than the carrying amount.
Amortization of patents and trademarks has been classified as research and development expense in the accompanying statement of operations. Estimated aggregate amortization expense based on current intangibles for the next four years is expected to be as follows: $102,000 for the remainder of 2012, $82,000 in 2013, $29,000 in 2014, and $1,000 in 2015.
13
8. BUSINESS SEGMENTS AND SIGNIFICANT CUSTOMERS:
Our electronic assembly segment designs, manufactures and sells optical process control sensors and inspection systems for the electronic assembly equipment market. Our semiconductor segment designs, manufactures and sells optical and other process control sensors and related equipment for the semiconductor capital equipment market. Information regarding our segments is as follows:
|
|
|
|
|
|
|
|
|
|
Three
Months Ended |
|
||||
(In thousands) |
|
2012 |
|
2011 |
|
||
Revenue: |
|
|
|
|
|
|
|
Electronic Assembly |
|
|
|
|
|
|
|
OEM Sensors |
|
$ |
4,178 |
|
$ |
6,092 |
|
SMT Systems |
|
|
5,551 |
|
|
5,379 |
|
Total Electronic Assembly |
|
|
9,729 |
|
|
11,471 |
|
Semiconductor |
|
|
1,551 |
|
|
1,879 |
|
Total |
|
$ |
11,280 |
|
$ |
13,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations: |
|
|
|
|
|
|
|
Electronic Assembly |
|
$ |
(396 |
) |
$ |
585 |
|
Semiconductor |
|
|
488 |
|
|
502 |
|
Total income from operations |
|
|
92 |
|
|
1,087 |
|
Interest income and other |
|
|
35 |
|
|
86 |
|
Income before taxes |
|
$ |
127 |
|
$ |
1,173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization: |
|
|
|
|
|
|
|
Electronic Assembly |
|
$ |
363 |
|
$ |
586 |
|
Semiconductor |
|
|
47 |
|
|
57 |
|
Total |
|
$ |
410 |
|
$ |
643 |
|
Export sales were 87% of revenue in the three months ended March 31, 2012 and 85% of revenue in the three months ended March 31, 2011. Virtually all of our export sales are negotiated, invoiced and paid in U.S. dollars. Export sales by geographic area are summarized as follows:
|
|
|
|
|
|
|
|
|
|
Three
Months Ended |
|
||||
(In thousands) |
|
2012 |
|
2011 |
|
||
|
|
|
|
|
|
|
|
Americas |
|
$ |
497 |
|
$ |
474 |
|
Europe |
|
|
3,386 |
|
|
4,529 |
|
Asia |
|
|
5,800 |
|
|
6,161 |
|
Other |
|
|
144 |
|
|
196 |
|
|
|
|
|
|
|
|
|
Total export sales |
|
$ |
9,827 |
|
$ |
11,360 |
|
We are dependent upon three electronic assembly customers, Juki, Assembleon, and LaserTek, a distributor of our inspection systems in China, for a significant portion of our total revenue. For the three months ended March 31, 2012, sales to Juki accounted for 19% of our total revenue, sales to Assembleon accounted for 14% of our total revenue and sales to LaserTek accounted for 13% of our total revenue.
14
9. NET INCOME PER SHARE:
Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Net income per diluted share is computed by dividing net income by the weighted average number of common and common equivalent shares outstanding during the period. Common equivalent shares consist of common shares to be issued upon exercise of stock options, restricted stock units and from participation in our employee stock purchase plan, as calculated using the treasury stock method. The components of net income per basic and diluted share are as follows:
|
|
|
|
|
|
|
|
|
|
|
(In thousands except per share amounts) |
|
Net Income |
|
Weighted |
|
Per Share |
|
|||
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2012: |
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
92 |
|
|
6,933 |
|
$ |
0.01 |
|
Dilutive effect of common equivalent shares |
|
|
|
|
|
49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive |
|
$ |
92 |
|
|
6,982 |
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands except per share amounts) |
|
Net Income |
|
Weighted |
|
Per Share |
|
|||
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2011: |
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
846 |
|
|
6,891 |
|
$ |
0.12 |
|
Dilutive effect of common equivalent shares |
|
|
|
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive |
|
$ |
846 |
|
|
6,935 |
|
$ |
0.12 |
|
The calculation of diluted net income per common share excludes 362,000 potentially dilutive shares for the three months ended March 31, 2012 and 321,000 potentially dilutive shares for the three months ended March 31, 2011, because their effect would be anti-dilutive.
10. COMPREHENSIVE INCOME:
Taxes related to items of other comprehensive income are as follows:
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
Before Tax |
|
Tax
(Expense)/ |
|
Net of Tax |
|
|||
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2012: |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
$ |
211 |
|
$ |
|
|
$ |
211 |
|
Unrealized losses on available-for-sale securities |
|
|
(6 |
) |
|
2 |
|
|
(4 |
) |
Unrealized gains on foreign exchange forward contracts |
|
|
323 |
|
|
(112 |
) |
|
211 |
|
Reclassification adjustment for gains (losses) on foreign exchange forward contracts included in net income |
|
|
75 |
|
|
(26 |
) |
|
49 |
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
|
$ |
603 |
|
$ |
(136 |
) |
$ |
467 |
|
15
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
Before Tax |
|
Tax
(Expense)/ |
|
Net of Tax |
|
|||
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2011: |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
$ |
98 |
|
$ |
|
|
$ |
98 |
|
Unrealized gains on available-for-sale securities |
|
|
10 |
|
|
(3 |
) |
|
7 |
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized losses on foreign exchange forward contracts |
|
|
(26 |
) |
|
9 |
|
|
(17 |
) |
Reclassification adjustment for gains (losses) on foreign exchange forward contracts included in net income |
|
|
27 |
|
|
(9 |
) |
|
18 |
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) |
|
$ |
109 |
|
$ |
(3 |
) |
$ |
106 |
|
Reclassification adjustments are made to avoid double counting in comprehensive income items that are also recorded as part of net income. Reclassifications to earnings related to cash flow hedging instruments are provided in Note 3. There were no reclassifications to earnings from accumulated other comprehensive income related to realized gains or losses on available for sale securities. Income taxes are not provided for foreign currency translation adjustments relating to permanent investments in international subsidiaries.
At March 31, 2012 and December 31, 2011 components of accumulated other comprehensive income (loss) is as follows:
|
|
|
|
|
|
|
|
(In thousands) |
|
March 31, |
|
December
31, |
|
||
|
|
|
|
|
|
|
|
Unrealized gains on available-for-sale securities |
|
$ |
14 |
|
$ |
18 |
|
Unrealized losses on effective portion of foreign exchange forward contracts, net |
|
|
(63 |
) |
|
(323 |
) |
Foreign currency translation adjustments |
|
|
(410 |
) |
|
(621 |
) |
|
|
|
|
|
|
|
|
Balance at end of period |
|
$ |
(459 |
) |
$ |
(926 |
) |
11. INCOME TAXES:
In the three months ended March 31, 2012, we recorded income tax expense of $35,000, compared to income tax expense of $327,000 in the same period of last year. Our effective tax rate was 28% in both the first quarter of 2012 and the first quarter of 2011. Our effective tax rate for 2012 and 2011 reflects the benefit of having a significant portion of our operations in Singapore where corporate income tax rates are substantially lower than the United States. Fluctuations in the level of income in the United States and Singapore will have an impact on our effective tax rate in any given annual period. We anticipate that our effective tax rate for all of 2012 will be approximately 25%.
We currently have significant deferred tax assets as a result of temporary differences between taxable income on our tax returns and U.S. GAAP income, research and development tax credit carry forwards and foreign net operating loss carry forwards. A deferred tax asset generally represents future tax benefits to be received when temporary differences previously reported in our financial statements become deductible for income tax purposes, or when net operating loss carry forwards are applied against future taxable income, or when tax credit carry forwards are utilized on our tax returns. We assess the realizability of our deferred tax assets and the need for a valuation allowance based on the guidance provided in current financial accounting standards.
16
Significant judgment is required in determining the realizability of our deferred tax assets. The assessment of whether valuation allowances are required considers, among other matters, the nature, frequency and severity of any current and cumulative losses, forecasts of future profitability, the duration of statutory carry forward periods, our experience with loss carry forwards not expiring unused and tax planning alternatives.
In analyzing the need for valuation allowances, we first considered our history of cumulative losses for U.S. income tax purposes over the past three years and also gave significant consideration to our results for U.S. income tax purposes over the past five years, as the economic cycles in our industry have tended to average five years in length. We also considered our forecasts of future profitability, the duration of statutory carry forward periods and tax planning alternatives. Finally, we considered the length and severity of the recent global economic crisis, the impact that it had on our operating results and our expectation for rebound given recent signs of recovery in the global economy and more specifically in our markets. After considering all of these factors, and after considering other significant positive evidence, we concluded that a valuation allowance, with respect to substantially all of our U.S. based deferred tax assets, was not required at March 31, 2012 and December 31, 2011.
Our results in both 2008 and 2009 were negatively impacted by the global economic slowdown, and we incurred a loss in the United States in both 2008 and 2009, where most of our net deferred tax assets are recorded. We recorded a profit in 2010 and 2011. Achievement of ongoing profitability in the United States will be a significant factor in determining our continuing ability to carry these deferred tax assets without recording a valuation allowance. If future results from our operations are less than projected, a valuation allowance may be required against virtually all of our deferred tax assets, which could have a material impact on our results of operations in the period in which it is recorded.
Deferred tax assets at March 31, 2012, include net operating loss carry forwards incurred in the UK by CyberOptics Ltd., which was acquired in 1999. The utilization of these net operating loss carry forwards is dependent on CyberOptics Ltd.s ability to generate sufficient UK taxable income during the carry forward period.
The valuation allowances at March 31, 2012 and December 31, 2011 are needed for various long-term state tax credit carry forwards, state operating loss carry forwards and capital losses for which recovery is not deemed to be more likely than not.
12. CONTINGENCIES:
We are periodically a defendant in miscellaneous claims and disputes in the ordinary course of business. While the outcome of these matters cannot be predicted with certainty, management presently believes the disposition of these matters will not have a material effect on our financial position, results of operations or cash flows.
In the normal course of business to facilitate sales of our products and services, we at times indemnify other parties, including customers, with respect to certain matters. In these instances, we have agreed to hold the other parties harmless against losses arising out of intellectual property infringement or other types of claims. These agreements may limit the time within which an indemnification claim can be made, and almost always limit the amount of the claim. It is not possible to determine the maximum potential amount under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. Historically, payments made, if any, under these agreements have not had a material impact on our operating results, financial position or cash flows.
13. RECENT ACCOUNTING DEVELOPMENTS:
In June 2011, the FASB issued amended disclosure requirements for the presentation of comprehensive income (ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income). The amended guidance eliminates the option to present components of other comprehensive income (OCI) as part of the statement of changes in equity. Under the amended guidance, all changes in OCI are to be presented either in a single continuous statement of comprehensive income or in two separate but consecutive financial statements. The FASB subsequently met on October 21, 2011 and decided that the specific requirement to present items that are reclassified from other comprehensive income to net income alongside their respective components of net income and other comprehensive income will be deferred. We adopted the remaining amended disclosure requirement changes effective January 1, 2012. Our adoption of the amended disclosure requirements had no impact on our consolidated financial results as the amendments relate only to changes in financial statement presentation.
17
ITEM 2 - MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CRITICAL ACCOUNTING POLICIES AND ESTIMATES:
The preparation of the financial information contained in this 10-Q requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate these estimates on an ongoing basis, including those related to allowances for doubtful accounts and returns, warranty obligations, inventory valuation, the carrying value and any impairment of intangible assets, income taxes and derivatives and hedging activities. These critical accounting policies are discussed in more detail in the Managements Discussion and Analysis of Financial Condition and Results of Operations contained in our Form 10-K for the year ended December 31, 2011.
FORWARD LOOKING STATEMENTS:
The following managements discussion and analysis contains a number of estimates and predictions that are forward looking rather than based on historical fact. Among other matters, we discuss (i) our level of anticipated revenues, gross margins, expenses, and net income for the second quarter and full year 2012; (ii) the potential margin improvements resulting from our next-generation solder paste inspection (SPI) and automated optical inspection (AOI) systems; (iii) the timing of initial revenue and margin improvements from other new products that we have under development, that have been recently introduced or we anticipate introducing in the future; (iv) our expectations regarding market acceptance of WaferSense and our other semiconductor products; (v) our beliefs regarding trends in the general economy and its impact on markets for our equipment; and (vi) the impact of currency fluctuations on our operations. Although we have made these statements based on our experience and best estimate of future events, there may be events or factors that we have not anticipated, and the accuracy of our statements and estimates are subject to a number of risks, including those identified in our Annual Report on Form 10-K for the year ended December 31, 2011.
RESULTS OF OPERATIONS:
General
Our products are sold primarily into the electronics assembly, photovoltaic (solar) cell manufacturing, semiconductor DRAM and Flash memory manufacturing, and semiconductor fabrication capital equipment markets. We sell products in these markets both to original equipment manufacturers of production equipment and to end-user customers that produce circuit boards, solar cells and semiconductor wafers and devices. Historically these markets have been very cyclical, and have experienced periods of rapid growth as worldwide capacity is added to support increased consumer demand for electronic products, and new capital equipment is purchased as a result of technology changes in electronics components, such as miniaturization, and changing production requirements. These periods of growth have historically been followed by periods of excess capacity and reduced capital spending.
Our results in the first three months of 2012 have been impacted by the absence of solar sensor sales and weakness in surface mount technology (SMT) alignment sensors due to weak SMT, semiconductor and solar market conditions. We believe the first quarter of 2012 likely marked the trough of a multi-quarter cyclical downturn in the global electronics industry. We have remained profitable throughout this downturn, in addition to increasing our share of the automated optical inspection market with our family of QX products. We believe this performance reflects the emphasis that we have placed in recent years on developing next-generation inspection systems, which have enabled us to compensate for short-term weakness in our SMT and solar alignment sensor businesses. By establishing a foundation for future growth and profitability, we anticipate improved operating results in future quarters as the global electronics market recovers from its recent period of weakness. In addition to generally weak market conditions, our first quarter operating results reflect the seasonal slowdown that we typically experience in the first and fourth quarters of most years, resulting from the normal buying patterns of our original design manufacturer, or ODM, customers.
Looking ahead to the second quarter, sales of inspection systems are expected to post year-over-year, double-digit growth, paced by continued strengthening of AOI product sales, including the new QX100 tabletop system. Our Asian based original design manufacturer (ODM) customers started placing significant AOI and SPI orders late in the first quarter, consistent with the fact that most new production capacity is installed during the second and third quarters. We ended the first quarter of 2012 with an order backlog of $5.6 million, up from $4.9 million at the end of last years fourth quarter. Given these factors, we are forecasting improved operating results for the second quarter of 2012 ending June 30, including strong demand for inspection systems and WaferSense products, the introduction of new products, and strengthening demand for both SMT and solar alignment sensors later in the year.
18
Segment Results
Operating results for our electronic assembly and semiconductor segments for the three month periods ended March 31, 2012 and 2011 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2012 |
|
Three months ended March 31, 2011 |
|
||||||||||||||
(In thousands) |
|
Electronic |
|
Semi- |
|
Total |
|
Electronic |
|
Semi- |
|
Total |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
9,729 |
|
$ |
1,551 |
|
$ |
11,280 |
|
$ |
11,471 |
|
$ |
1,879 |
|
$ |
13,350 |
|
Cost of revenues |
|
|
5,597 |
|
|
448 |
|
|
6,045 |
|
|
6,143 |
|
|
600 |
|
|
6,743 |
|
Gross margin |
|
|
4,132 |
|
|
1,103 |
|
|
5,235 |
|
|
5,328 |
|
|
1,279 |
|
|
6,607 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development expenses |
|
|
1,633 |
|
|
284 |
|
|
1,917 |
|
|
1,520 |
|
|
298 |
|
|
1,818 |
|
Selling, general and administrative expenses |
|
|
2,895 |
|
|
331 |
|
|
3,226 |
|
|
3,196 |
|
|
461 |
|
|
3,657 |
|
Amortization of intangibles |
|
|
|
|
|
|
|
|
|
|
|
27 |
|
|
18 |
|
|
45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations |
|
$ |
(396 |
) |
$ |
488 |
|
$ |
92 |
|
$ |
585 |
|
$ |
502 |
|
$ |
1,087 |
|
Revenues
Our revenues decreased by 16% to $11.3 million in the three months ended March 31, 2012 from $13.4 million in the three months ended March 31, 2011. The following table sets forth revenues by product line for the three month periods ended March 31, 2012 and 2011:
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
||||
(In thousands) |
|
2012 |
|
2011 |
|
||
|
|
|
|
|
|
|
|
Electronic Assembly |
|
|
|
|
|
|
|
OEM Alignment Sensors |
|
$ |
4,178 |
|
$ |
6,092 |
|
SMT Inspection Systems |
|
|
5,551 |
|
|
5,379 |
|
Total Electronic Assembly |
|
|
9,729 |
|
|
11,471 |
|
Semiconductor |
|
|
1,551 |
|
|
1,879 |
|
Total |
|
$ |
11,280 |
|
$ |
13,350 |
|
Electronic Assembly
Revenue from sales of our OEM alignment sensors decreased by $1.9 million or 31% to $4.2 million in the three months ended March 31, 2012, down from $6.1 million in the three months ended March 31, 2011. Sales of OEM alignment sensors declined from the year-earlier period due to sluggish SMT, semiconductor and solar market conditions. Revenue from sales of solar wafer alignment cameras which accounted for $1.6 million of revenue in the first quarter of 2011, were nil in this years first quarter, reflecting the continued impact of excess production capacity in the photovoltaic cell market. We do not anticipate any material strengthening in the solar market until later in 2012. Sales of SMT alignment sensors were down $274,000 or 7% in the first quarter of 2012 compared to the first quarter of 2011. We believe sales of OEM alignment sensors should start rebounding in the second half of the year, as we believe the first quarter of 2012 likely marked the trough of a multi-quarter cyclical downturn in the global electronics industry.
Revenue from sales of our stand-alone SMT inspection systems products increased by $172,000 or 3% to $5.6 million in the three months ended March 31, 2012, up from $5.4 million in the three months ended March 31, 2011. Sales of AOI systems increased by $875,000 or 39% in the three months ended March 31, 2012, led by our next-generation QX500 AOI system, as we capitalized both on our existing relationships with several of the worlds largest ODMs and established relationships with 13 new AOI customers.
19
The QX500 is based upon a cost-reduced platform that we believe offers the fastest AOI inspection times currently available. We believe the QX500 will continue to receive favorable market acceptance, particularly with ODMs, where we have an established installed base of SPI systems and where the fast inspection times of the QX500 are required. Increased sales of AOI systems in the three months ended March 31, 2012 were partially offset by a reduction in sales of our SPI systems. Sales of SPI systems declined by $840,000 or 31% to $1.9 million in the three months ended March 31, 2012, from $2.8 million in the three months ended March 31, 2011, due to an overall sluggish global electronics market and increased competition. We are anticipating an approximate 10% increase in second quarter stand-alone SMT inspection system sales, on a year-over-year basis, reflecting continued strong demand for our inspection systems from global electronics manufacturers.
We believe that ongoing introduction of new system products addressing different tiers of the market will strengthen our competitive position in the inspection market. For example, we recently introduced a new lower-end AOI tabletop system and a higher-performance SPI system based upon a newly developed dual illumination sensor. We realized the initial sales of our new QX100 off-line AOI tabletop system in the first quarter of 2012. Revenue from QX100 off-line AOI tabletop systems totaled $324,000 in the three months ended March 31, 2012.
Export revenue from OEM alignment sensors and SMT inspection systems totaled $9.0 million or 93% of electronic assembly revenue in the three months ended March 31, 2012, compared to $10.5 million or 91% of electronic assembly revenue in the three months ended March 31, 2011. Sales to international customers continue to be significant, as manufacturing of electronic components has migrated offshore, particularly to China and other areas of Asia.
Semiconductor
Revenues from sales of our semiconductor products decreased by $328,000 or 17% in the three months ended March 31, 2012, from $1.9 million in the three months ended March 31, 2011. The decrease in revenue was primarily due to sluggish market conditions in the global semiconductor market.
Our wafer mapper and frame grabber products are relatively mature. We anticipate that future growth in our semiconductor revenues, exclusive of changes related to capital procurement cycles will come from our new WaferSense products, a family of wireless, wafer-like precision measurement tools for in-situ setup, calibration and process optimization in semiconductor processing equipment. In the first quarter of 2012 we introduced our new WaferSense particle sensor and anticipate introducing additional WaferSense products in future periods. WaferSense revenue decreased by $108,000 or 9% to $1.0 million in the three months ended March 31, 2012 from approximately $1.1 million in the three months ended March 31, 2011. We presently anticipate that revenue from semiconductor products in the second quarter of 2012 will increase by approximately 10% from the first quarter 2012 level as conditions in the global semiconductor market continue to improve.
Export revenue from semiconductor products totaled $777,000 or 50% of revenue in the three months ended March 31, 2012, compared to $898,000 or 48% of revenue in the three months ended March 31, 2011. We anticipate that the percentage of export revenue will continue to grow in the future as a higher proportion of our WaferSense sales come from international customers compared to our other semiconductor products.
Cost of Revenue and Gross Margin
Electronic Assembly
Cost of revenue for our electronic assembly segment decreased by $546,000 or 9% in the three months ended March 31, 2012, due to lower sales volume when compared to the same period of 2011. Gross margin as a percentage of electronic assembly sales was 42% in the three months ended March 31, 2012, compared to 46% in the three months ended March 31, 2011, due largely to the $1.6 million decrease in solar wafer alignment camera revenues, which carry a higher gross margin than our other products. Partially offsetting the negative gross margin impact resulting from the reduced volume of solar wafer alignment cameras are the ongoing shift in our product mix to higher margin QX AOI systems.
We anticipate that gross margins as a percentage of electronic assembly sales in the second quarter of 2012 may decline by a few percentage points when compared to the level in the first quarter of 2012 due to a shift in our overall sales mix toward lower gross margin inspection systems, particularly SPI systems, which carry a lower gross margin than our AOI systems and more high unit volume system sales to Asian ODMs that typically entail lower price points.
20
The electronic assembly market is highly price competitive, resulting in continual pressure on our gross margins. We compensate for pricing pressure by introducing new products with more features and improved performance and through manufacturing cost reduction programs. For example, our latest stand-alone SMT inspection system products combine a reduction in cost with enhanced performance. Other recently introduced products, including our QX100 off-line AOI tabletop system, solar wafer alignment camera, embedded process verification (EPV) technology and the 3D SE500 SPI sensors we sell to Viscom AG, have more favorable margins than our existing products.
Semiconductor
Cost of revenue for our semiconductor segment decreased by $152,000 or 25% for the three months ended March 31, 2012, due to lower sales volume when compared to the same period of 2011. Gross margin as a percentage of semiconductor sales increased to 71% in the three months ended March 31, 2012 from 68% in the three months ended March 31, 2011. The gross margin percentage increase was due to lower scrap charges in the first quarter of 2012 when compared to the same period of 2011.
We anticipate that gross margin as a percentage of semiconductor sales in the second quarter of 2012 will be the same or slightly higher than the first quarter of 2012.
Operating Expenses
We believe continued investment in research and development of new products, coupled with continued investment in and development of our sales channel is critical to future growth and profitability. We historically have maintained research and development and sales and marketing expenses at relatively high levels, even during periods of recession and downturn in our electronic assembly and semiconductor capital equipment markets, as we continue to fund development of important new products, and continue to invest in our sales channels and develop new sales territories.
Electronic Assembly
Research and development expense for our electronic assembly segment was $1.6 million in the three months ended March 31, 2012, compared to $1.5 million in the three months ended March 31, 2011. The slight increase in research and development expense in the three months ended March 31, 2012 resulted from higher costs for additional wages and benefits due to pay increases and headcount additions, offset in part by lower project development costs for proto-types and contractors. We anticipate that research and development expense in the second quarter of 2012 will be higher than the first quarter level as development continues on new products, particularly our stand-alone SMT inspection system products.
Selling, general and administrative expense for our electronic assembly segment was $2.9 million in the three months ended March 31, 2012, compared to $3.2 million in the three months ended March 31, 2011. The decrease in selling, general and administrative expense in the three months ended March 31, 2012 was due to a reduction in commissions for third party sales representatives, as more sales were sold through distribution channels, reduced travel expense, and a $48,000 reduction in our allowance for doubtful accounts, resulting from partial recovery of a receivable we reserved for in a prior period.
We presently anticipate that selling, general and administrative expense in the second quarter of 2012 will be 10% to 15% above the level recorded in the three months ended March 31, 2012 reflecting increased internal and third party sales commissions on anticipated higher sales.
Semiconductor
Research and development expense for our semiconductor segment was $284,000 in the three months ended March 31, 2012, compared to $298,000 in the three months ended March 31, 2011. Research and development expense was slightly lower in the first quarter 2012 compared to the first quarter of 2011 due to decreased expenditures for proto-types, partially offset by higher wage and benefit costs.
Selling, general and administrative expenses for our semiconductor segment were $331,000 in the three months ended March 31, 2012 compared to $461,000 in the three months ended March 31, 2011. The decrease in expense in the three months ended March 31, 2012 reflects lower third party sales commission expenses as a result of lower sales. No significant changes are expected in the level of semiconductor operating expenses in the second quarter of 2012.
21
Interest Income and Other
Interest income and other includes interest earned on investments and gains and losses associated with foreign currency transactions and foreign exchange forward contracts used to hedge against the effects of exchange rate fluctuations on intercompany financing transactions associated with our subsidiaries in the United Kingdom and Singapore. Interest income and other decreased in the three months ended March 31, 2012, compared to the same period of 2011, reflecting lower interest income resulting from lower rates of interest earned on invested funds. In addition, fluctuations in the level of gains and losses associated with foreign currency transactions and foreign exchange forward contracts can also impact the level of interest income and other reported in any given period. Other income from foreign currency transactions and foreign exchange forward contracts was $35,000 in the three months ended March 31, 2012, compared to $76,000 in the same period of 2011.
Provision for Income Taxes and Effective Income Tax Rate
In the three months ended March 31, 2012, we recorded income tax expense of $35,000, compared to income tax expense of $327,000 in the same period of last year. The reduction in income tax expense was due to the lower level of income reported in the first quarter of 2012. Our effective tax rate was 28% in both the first quarter of 2012 and the first quarter of 2011. Our effective tax rate for 2012 and 2011 reflects the benefit of having a significant portion of our operations in Singapore where corporate income tax rates are substantially lower than the United States. Fluctuations in the level of income in the United States and Singapore will have an impact on our effective tax rate in any given annual period. We anticipate that our effective tax rate for all of 2012 will be approximately 25%.
Order Rate and Backlog
Our orders totaled $12.0 million in the three months ended March 31, 2012, compared to $12.3 million in the three months ended December 31, 2011 and $16.8 million in the three months ended March 31, 2011. Backlog totaled $5.6 million at March 31, 2012, $4.9 million at December 31, 2011 and $10.6 million at March 31, 2011. The scheduled shipment (or estimated timing of revenue for systems recognized upon acceptance) for backlog at March 31, 2012 is as follows:
|
|
|
|
|
(In thousands) |
|
Backlog |
|
|
|
|
|
|
|
2th Quarter 2012 |
|
$ |
4,701 |
|
3rd Quarter 2012 and after |
|
|
891 |
|
Total backlog |
|
$ |
5,592 |
|
22
LIQUIDITY AND CAPITAL RESOURCES
Our cash and cash equivalents decreased by $3.9 million in the three months ended March 31, 2012, resulting from $4.7 million of new marketable security purchases, net of proceeds from maturities and sales of marketable securities and purchases of capital assets totaling $437,000, offset in part by $1.2 million of cash provided by operating activities. Our cash and cash equivalents fluctuate in part because of maturities of marketable securities, and investment of cash balances in marketable securities, or from other sources of cash, in addition to marketable securities. Accordingly, we believe the combined balances of cash and marketable securities provide a more reliable indication of our available liquidity. Combined balances of cash and marketable securities increased by $837,000 to $31.4 million as of March 31, 2012 from $30.5 million as of December 31, 2011.
Operating activities provided $1.2 million of cash in the three months ended March 31, 2012. Cash provided by operations included net income of $92,000, which included non-cash expenses totaling $477,000 for depreciation and amortization, provision for doubtful accounts, non-cash gains and losses from foreign currency transactions and stock compensation expenses.
Changes in operating assets and liabilities using cash included increases in inventories of $1.4 million, increases in other assets of $91,000, decreases in accrued expenses of $379,000 and decreases in advance customer payments of $58,000. Changes in operating assets and liabilities providing cash included decreases in accounts receivable of $1.6 million and increases in accounts payable of $1.0 million. Inventories increased as first quarter 2012 sales levels were lower than anticipated. Accrued expenses and other liabilities decreased due to lower commission and incentive compensation accruals, resulting from lower sales levels in the first quarter of 2012 and payment of 2011 incentive compensation accruals in the three months ended March 31, 2012. The decrease in accounts receivable was due to lower sales levels in the first quarter of 2012, compared to the fourth quarter of 2011, resulting in more cash receipts compared to new sales in the quarter. The increase in accounts payable resulted from increased material purchases near the end of the first quarter. These materials will be paid for in the second quarter of 2012.
Operating activities provided $460,000 of cash in the three months ended March 31, 2011. Cash provided by operations included net income of $846,000, which included non-cash expenses totaling $924,000 for depreciation and amortization, deferred taxes, non-cash gains and losses from foreign currency transactions and stock compensation costs. Changes in operating assets and liabilities using cash included increases in inventories of $359,000, decreases in accounts payable of $872,000, advance customer payments of $298,000 and accrued expenses of $160,000. Changes in operating assets and liabilities providing cash included decreases in accounts receivable of $260,000 and other assets of $138,000. Inventories were higher due to differences between actual and forecasted sales for varying types of alignment sensors to specific OEM customers, and an increase in customer orders with acceptance conditions at March 31, 2011 compared to December 31, 2010. The decrease in accounts payable resulted from the timing of raw material purchases and the need to pay for more purchases prior to March 31, 2011, as compared to December 31, 2010. Advance customer payments decreased due to typical fluctuations in the timing of customer prepayments. Accrued expenses and other liabilities decreased due to payment of 2010 bonus accruals in the three months ended March 31, 2011. Accounts receivable decreased slightly due to proportionately higher sales of alignment sensors and semiconductor products, as these customers tend to pay faster than our systems customers. Other assets decreased due to collection of accrued interest receivable.
Investing activities used $5.1 million of cash in the three months ended March 31, 2012 compared to providing $638,000 of cash in the same period last year. Changes in the level of investment in marketable securities, resulting from the purchases, sales and maturities of those securities used $4.7 million of cash in the three months ended March 31, 2012, compared to generating $743,000 of cash in the same period last year. We used $437,000 of cash in the three months ended March 31, 2012 for the purchase of fixed asset and capitalized patent costs, compared to using $105,000 of cash for this purpose in the three months ended March 31, 2011.
There were no significant financing activities in either the three months ended March 31, 2012 or the three months ended March 31, 2011.
At March 31, 2012, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of establishing off-balance sheet arrangements or other contractually narrow or limited purposes.
A table of our contractual obligations was provided in Item 7 in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011. There have been no significant changes to our contractual obligations in the three months ended March 31, 2012. At the present time, we have no material commitments for capital expenditures. Purchase commitments for inventory will vary based on the volume of revenue and resulting inventory requirements.
23
Our cash, cash equivalents and marketable securities totaled $31.4 million at March 31, 2012. We believe that our available balances of cash, cash equivalents and marketable securities will be adequate to fund our cash flow needs for the foreseeable future.
Inflation and Foreign Currency Transactions
Changes in our revenues have resulted primarily from changes in the level of unit shipments and the relative strength of the worldwide electronics and semiconductor fabrication capital equipment markets. We believe that inflation has not had a significant effect on our operations.
Virtually all of our international export sales are negotiated, invoiced and paid in U.S. dollars. We manufacture our SMT system products in Singapore and a portion of our raw material purchases are denominated in Singapore dollars. We also have R&D and sales personnel located in Singapore and sales offices located in other parts of the world who are paid in local currency. Although currency fluctuations do not significantly affect our revenue, they can impact our costs and influence the price competitiveness of our products and the willingness of existing and potential customers to purchase units.
We enter into foreign exchange forward contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies and certain intercompany financing transactions associated with our subsidiaries in the United Kingdom and Singapore. These transactions are designated as cash flow hedges. The effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged transaction affects earnings. The maximum length of time over which we hedge our exposure to the variability in future cash flows is 12 months and, accordingly, at March 31, 2012, all of our open foreign exchange forward contracts had maturities of one year or less. The dollar equivalent gross notional amount of our foreign exchange forward contracts designated as cash flow hedges at March 31, 2012 was approximately $10.8 million.
At March 31, 2012, our open foreign exchange forward contracts were in an unrealized loss position equal to $97,000 on a pre-tax basis due to a strengthening of the U.S. dollar in relation to the Singapore dollar during the time from when we first entered into these contracts through March 31, 2012. If the exchange rate between the U.S. dollar and the Singapore dollar were to remain unchanged over the next twelve months, we would realize this pre-tax loss through our statement of operations. However, because we do not fully hedge all of our future anticipated cash flows in Singapore dollars, the portion of our costs that we do not hedge would be lower in relation to recent quarters. If the U.S. dollar were to weaken in future periods in relation to the Singapore dollar, the unrealized loss on our open foreign exchange forward contracts would be reduced, but costs that are not hedged would increase. The ultimate impact of any fluctuation in the relationship between the U.S. dollar and Singapore dollar is dependent on the level of Singapore denominated cash flows in future periods.
Recent Accounting Developments
In June 2011, the FASB issued amended disclosure requirements for the presentation of comprehensive income (ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income). The amended guidance eliminates the option to present components of other comprehensive income (OCI) as part of the statement of changes in equity. Under the amended guidance, all changes in OCI are to be presented either in a single continuous statement of comprehensive income or in two separate but consecutive financial statements. The FASB subsequently met on October 21, 2011 and decided that the specific requirement to present items that are reclassified from other comprehensive income to net income alongside their respective components of net income and other comprehensive income will be deferred. We adopted the remaining amended disclosure requirement change guidance effective January 1, 2012. Our adoption of the amended disclosure requirements had no impact on our consolidated financial results as the amendments relate only to changes in financial statement presentation.
24
ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not applicable.
ITEM 4 CONTROLS AND PROCEDURES
a. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the Exchange Act)). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in applicable rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.
b. During the quarter ended March 31, 2012, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1A RISK FACTORS
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2011, which could materially affect our business, financial condition or future results.
ITEM 6 EXHIBITS
|
|
31.1: |
Certification of Chief Executive Officer pursuant to Rule 15d-14(a)(17 CFR 240.15d-14(a)) and Section 302 of the Sarbanes Oxley Act of 2002 |
|
|
31.2: |
Certification of Chief Financial Officer pursuant to Rule 15d-14(a)(17 CFR 240.15d-14(a)) and Section 302 of the Sarbanes Oxley Act of 2002 |
|
|
32: |
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes Oxley Act of 2002 |
|
|
101: |
Financial statements formatted in Extensible Business Reporting Language: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statement of Operations, (iii) the Condensed Consolidated Statements of Cash Flows and (iv) the Notes to the Interim Condensed Consolidated Financial Statements. |
25
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
CYBEROPTICS CORPORATION |
|
|
|
|
|
/s/ Kathleen P. Iverson |
|
|
By Kathleen P. Iverson, Chief Executive Officer and Chair |
|
|
(Principal Executive Officer and Duly Authorized Officer) |
|
|
|
|
|
/s/ Jeffrey A. Bertelsen |
|
|
By Jeffrey A. Bertelsen, Chief Financial Officer |
|
|
(Principal Accounting Officer and Duly Authorized Officer) |
|
||
Dated: May 10, 2012 |
|
|
26
EXHIBIT 31.1
|
|
I, Kathleen P. Iverson, certify that: |
|
|
|
1. I have reviewed this Quarterly Report on Form 10-Q of CyberOptics Corporation. |
|
|
|
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
|
|
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
|
|
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
|
|
|
|
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
|
|
|
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: May 10, 2012
|
|
|
|
/s/ Kathleen P. Iverson |
|
|
Signature |
|
|
Name: |
Kathleen P. Iverson |
|
Title: |
Chief Executive Officer and Chair |
27
EXHIBIT 31.2
|
|
I, Jeffrey A. Bertelsen, certify that: |
|
|
|
1. I have reviewed this Quarterly Report on Form 10-Q of CyberOptics Corporation. |
|
|
|
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
|
|
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
|
|
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
|
|
|
|
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
|
|
|
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: May 10, 2012
|
|
|
|
/s/ Jeffrey A. Bertelsen |
|
|
Signature |
|
|
Name: |
Jeffrey A. Bertelsen |
|
Title: |
Chief Financial Officer |
28
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CyberOptics Corporation (the Company) on Form 10-Q for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on or about the date hereof (the Report), the undersigned, Kathleen P. Iverson, Chief Executive Officer, and Jeffrey A. Bertelsen, Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
|
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
|
|
|
/s/ Kathleen P. Iverson |
|
|
Kathleen P. Iverson |
|
|
Chief Executive Officer |
|
|
May 10, 2012 |
|
|
|
|
|
/s/ Jeffrey A. Bertelsen |
|
|
Jeffrey A. Bertelsen |
|
|
Chief Financial Officer |
|
|
May 10, 2012 |
|
|
|
|
|
END OF FILING |
|
29
XCI@,Q^4)!E:U[;AU6NTVN``%HFHK@\ZJ0&52+<<`.7DN-X>
M5(D/-+#4W['ZSC/`7]`\".N@[>]EXP,/^`$,CW9]\_'VRY5V?_G_KN[>X!K?+$']#]4\-)IP:I\R/+XGQ1BFJ4893[4
M4A/JPVG+`77(X&)6F;B;@:I(`Q*==@60QG+K`GN>^-K=9??)R_:!QA/_V@<4
MV-(Z3@"D/O6#UJG^8>_3QX][1T=_J/\8,]C\\OG:URI>I>?D5E=`O;-$FM
]9#3%F-G;8R^4=?6WBZN
M._4##B5DS`W4=WHXN&-TCIFWO'-0&"/_PR=!&F+^1J&H2S_0H2UA?N1?<_#`
M+`,:[TSM(](9ZB#\U8OM^.+\XQ=*Q\_$<7*W%?*N_8!*:4ECR/0L.BD!1K^,
MKV3@GD49$[LJZ4HBLVT_3*\N6HR#IB**+=I@2@%1W*D?R"@A8PR1G@4BXXMM
M!7O,?IB\0);8M%6#B]G;RA,SAOU"T"-Q@DV3N/TG,F2>J`."
^PAXN+Q%6(NK+-X0E.P
M[R
Derivatives
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivatives [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivatives | 3. DERIVATIVES: We enter into foreign exchange forward contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies and certain intercompany financing transactions associated with our subsidiaries in the United Kingdom and Singapore. These transactions are designated as cash flow hedges. The effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. Hedge ineffectiveness and the amounts excluded from effectiveness testing recognized in income on cash flow hedges were not material for the three month periods ended March 31, 2012 and March 31, 2011. The maximum length of time over which we hedge our exposure to the variability in future cash flows is 12 months. Accordingly, at March 31, 2012 and March 31, 2011, all of our open foreign exchange forward contracts had maturities of one year or less. The dollar equivalent gross notional amount of our foreign exchange forward contracts designated as cash flow hedges was approximately $10.8 million at March 31, 2012 and $9.7 million at March 31, 2011. The location in the consolidated statements of operations and comprehensive income and amounts of gains and losses related to derivative instruments designated as cash flow hedges are as follows. Reclassifications of amounts from accumulated other comprehensive income into income include accumulated gains (losses) at the time earnings are impacted by the forecasted transaction.
Amounts recorded in accumulated other comprehensive loss for the after tax net unrealized loss associated with cash flow hedging instruments was $63,000 as of March 31, 2012 and $323,000 as of December 31, 2011. We expect to reclassify the March 31, 2012 after tax net unrealized loss recorded in accumulated other comprehensive loss to earnings over the next 12 months with the impact offset by cash flows from underlying hedged items. The fair value of our foreign exchange forward contracts representing a loss in the amount of $97,000 as of March 31, 2012 and $493,000 as of December 31, 2011 has been recorded in accrued expenses in the accompanying consolidated balance sheets. Additional information with respect to the impact of derivative instruments on other comprehensive income is included in Note 10. Additional information with respect to the fair value of derivative instruments is included in Note 4. Our foreign exchange forward contracts contain credit risk to the extent that our bank counter-parties may be unable to meet the terms of the agreements. We minimize such risk by limiting our counter-parties to major financial institutions. We do not expect material losses as a result of defaults by other parties. |